Prostatic tissue testosterone and dihydrotestosterone in African-American and white men

Urology

Volumn 68, Issue 2, 2006, Pages 337-341

  Marks, Leonard S ^a,b   Hess, David L ^c,d   Dorey, Frederick J ^e   Macairan, Maria L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Urological Sci Research Foundation   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Oregon National Primate Center   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; OXIDOREDUCTASE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CHROMATOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACTION; FROZEN SECTION; HORMONE ACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; RADIOIMMUNOASSAY; SEPARATION TECHNIQUE;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIOPSY; DIHYDROTESTOSTERONE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE; TESTOSTERONE;

EID: 33746849355     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.013     Document Type: Article

References (32)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Tarman G.J., Kane C.J., Moul J.W., et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56 (2000) 1016-1020
3. Hoffman R.M., Gilliland F.D., Eley J.W., et al. Racial and ethnic differences in advanced-stage prostate cancer. the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93 (2001) 388-395
4. Ross R., Bernstein L., Judd H., et al. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76 (1986) 45-48
5. Gapstur S.M., Gann P.H., Kopp P., et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11 (2002) 1041-1047
6. Kubricht III W.S., Williams B.J., Whatley T., et al. Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology 54 (1999) 1035-1038
7. Winters S.J., Brufsky A., Weissfeld J., et al. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50 (2001) 1242-1247
8. Mohler J.L., Gaston K.E., Moore D.T., et al. Racial differences in prostate androgen levels in men with clinically localized prostate cancer. J Urol 171 (2004) 2277-2280
9. Asbell S.O., Raimane K.C., Montesano A.T., et al. Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients. J Natl Med Assoc 92 (2000) 445-449
10. McConnell J.D., Wilson J.D., George F.W., et al. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab 74 (1992) 505-508
11. Marks L.S., Hess D.L., Dorey F.J., et al. Tissue effects of saw palmetto and finasteride. use of biopsy cores for in situ quantification of prostatic androgens. Urology 57 (2001) 999-1005
12. Alavi A.S., Soloway M.S., Vaidya A., et al. Local anesthesia for ultrasound guided prostate biopsy. a prospective randomized trial comparing 2 methods. J Urol 166 (2001) 1343-1345
13. Marks L.S., Epstein J.I., and Partin A.W. The role of prostate needle biopsy in evaluation of chemopreventive agents. Urology 57 (2001) 191-193
14. Zaridze D.G., and Boyle P. Cancer of the prostate. epidemiology and aetiology. Br J Urol 59 (1987) 493-502
15. Bruchovsky N., and Wilson J.D. The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate. J Biol Chem 243 (1968) 5953-5960
16. Lunn R.M., Bell D.A., Mohler J.L., et al. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis 20 (1999) 1727-1731
17. Makridakis N.M., Ross R.K., Pike M.C., et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet 354 (1999) 975-978
18. Salam M.T., Ursin G., Skinner E.C., et al. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer. Urol Oncol 23 (2005) 246-253
19. Belanger A., Hum D.W., Beaulieu M., et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 65 (1998) 301-310
20. Henderson B.E., Bernstein L., Ross R.K., et al. The early in utero oestrogen and testosterone environment of blacks and whites. potential effects on male offspring. Br J Cancer 57 (1988) 216-218
21. Osegbe D.N., and Ogunlewe J.O. Androgen concentration in blacks with benign and malignant prostatic disease. J Urol 140 (1988) 160-164
22. Coffey D.S., and Walsh P.C. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17 (1990) 461-475
23. Wu A.H., Whittemore A.S., Kolonel L.N., et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4 (1995) 735-741
24. Bennett C.L., Price D.K., Kim S., et al. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol 20 (2002) 3599-3604
25. Platz E.A., Rimm E.B., Willett W.C., et al. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92 (2000) 2009-2017
26. Guo Y., Sigman D.B., Borkowski A., et al. Racial differences in prostate cancer growth. apoptosis and cell proliferation in Caucasian and African-American patients. Prostate 42 (2000) 130-136
27. Caruso R.P., Levinson B., Melamed J., et al. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with Caucasian prostate cancer patients. Clin Cancer Res 10 (2004) 222-227
28. Kittles R.A., Panguluri R.K., Chen W., et al. Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans. Cancer Epidemiol Biomarkers Prev 10 (2001) 943-947
29. Petrovics G., Zhang W., Makarem M., et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23 (2004) 605-611
30. Tricoli J.V., Winter D.L., Hanlon A.L., et al. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology 54 (1999) 178-182
31. Enokida H., Shiina H., Urakami S., et al. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 116 (2005) 174-181
32. Marks L.S., Treiger B., Dorey F.J., et al. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands. Urology 44 (1994) 486-492